| Retinitis pigmentosa: genes and disease mechanisms S Ferrari, E Di Iorio, V Barbaro, D Ponzin, F S Sorrentino, F Parmeggiani Current genomics 12 (4), 238-249, 2011 | 692 | 2011 |
| Mechanism of inflammation in age‐related macular degeneration F Parmeggiani, MR Romano, C Costagliola, F Semeraro, C Incorvaia, ... Mediators of inflammation 2012 (1), 546786, 2012 | 179 | 2012 |
| Aflibercept in wet AMD: specific role and optimal use F Semeraro, F Morescalchi, S Duse, F Parmeggiani, E Gambicorti, ... Drug design, development and therapy, 711-722, 2013 | 160 | 2013 |
| Good epidemiologic practice in retinitis pigmentosa: from phenotyping to biobanking M Chizzolini, A Galan, E Milan, A Sebastiani, C Costagliola, ... Current genomics 12 (4), 260-266, 2011 | 154 | 2011 |
| Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications C Campa, C Costagliola, C Incorvaia, C Sheridan, F Semeraro, ... Mediators of inflammation 2010 (1), 546826, 2010 | 123 | 2010 |
| SSRIs and intraocular pressure modifications: evidence, therapeutic implications and possible mechanisms C Costagliola, F Parmeggiani, A Sebastiani CNS drugs 18, 475-484, 2004 | 117 | 2004 |
| Editorial [hot topic: clinics, epidemiology and genetics of retinitis pigmentosa (guest editor: francesco parmeggiani)] F Parmeggiani Current genomics 12 (4), 236-237, 2011 | 107 | 2011 |
| Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure C Costagliola, F Parmeggiani, F Semeraro, A Sebastiani Current Neuropharmacology 6 (4), 293-310, 2008 | 101 | 2008 |
| Central serous chorioretinopathy: pathogenesis and management F Semeraro, F Morescalchi, A Russo, E Gambicorti, A Pilotto, ... Clinical ophthalmology, 2341-2352, 2019 | 95 | 2019 |
| Ocular surface changes induced by topical application of latanoprost and timolol: a short-term study in glaucomatous patients with and without allergic conjunctivitis C Costagliola, A Del Prete, C Incorvaia, R Fusco, F Parmeggiani, ... Graefe's archive for clinical and experimental ophthalmology 239, 809-814, 2001 | 93 | 2001 |
| Diabetic retinopathy and endothelin system: microangiopathy versus endothelial dysfunction FS Sorrentino, S Matteini, C Bonifazzi, A Sebastiani, F Parmeggiani Eye 32 (7), 1157-1163, 2018 | 92 | 2018 |
| Therapeutic challenges to retinitis pigmentosa: from neuroprotection to gene therapy J N Sahni, M Angi, C Irigoyen, F Semeraro, M R Romano, F Parmeggiani Current genomics 12 (4), 276-284, 2011 | 92 | 2011 |
| Mechanism of inflammation in age‐related macular degeneration: an up‐to‐date on genetic landmarks F Parmeggiani, FS Sorrentino, MR Romano, C Costagliola, F Semeraro, ... Mediators of inflammation 2013 (1), 435607, 2013 | 82 | 2013 |
| Topical nonsteroidal anti‐inflammatory drugs for macular edema A Russo, C Costagliola, L Delcassi, F Parmeggiani, MR Romano, ... Mediators of inflammation 2013 (1), 476525, 2013 | 78 | 2013 |
| Pharmacotherapy of intraocular pressure: part I. Parasympathomimetic, sympathomimetic and sympatholytics C Costagliola, R Dell'Omo, MR Romano, M Rinaldi, L Zeppa, ... Expert opinion on Pharmacotherapy 10 (16), 2663-2677, 2009 | 77 | 2009 |
| Clinical and rehabilitative management of retinitis pigmentosa: up-to-date F Parmeggiani, G Sato, K De Nadai, M R Romano, A Binotto, ... Current genomics 12 (4), 250-259, 2011 | 69 | 2011 |
| Reading performance in patients with retinitis pigmentosa: a study using the MNREAD charts G Virgili, C Pierrottet, F Parmeggiani, M Pennino, G Giacomelli, ... Investigative ophthalmology & visual science 45 (10), 3418-3424, 2004 | 66 | 2004 |
| Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial AM Khanani, SS Patel, G Staurenghi, R Tadayoni, CJ Danzig, ... The Lancet 402 (10411), 1449-1458, 2023 | 63 | 2023 |
| Administration of sulpiride or domperidone for advancing the first ovulation in deep anestrous mares G Mari, M Morganti, B Merlo, C Castagnetti, F Parmeggiani, N Govoni, ... Theriogenology 71 (6), 959-965, 2009 | 55 | 2009 |
| Systemic adverse drug reactions secondary to anti-VEGF intravitreal injection in patients with neovascular age-related macular degeneration F Semeraro, F Morescalchi, F Parmeggiani, B Arcidiacono, C Costagliola Current vascular pharmacology 9 (5), 629-646, 2011 | 49 | 2011 |
